These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 3195146)
1. [Persistence of the tick-borne encephalitis virus in the vaccinated organism]. Levina LS; Pogodina VV Vopr Virusol; 1988; 33(4):485-90. PubMed ID: 3195146 [No Abstract] [Full Text] [Related]
2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
3. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents]. Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069 [TBL] [Abstract][Full Text] [Related]
5. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis]. Nikonova AN; Rozhkova LV; Sokolova ED Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848 [No Abstract] [Full Text] [Related]
6. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis]. Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575 [TBL] [Abstract][Full Text] [Related]
7. Vaccination against tick-borne encephalitis--distant evaluation. Bobrowska E; Grzeszczuk A; Prokopowicz D Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804 [TBL] [Abstract][Full Text] [Related]
8. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis. Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789 [TBL] [Abstract][Full Text] [Related]
10. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory]. Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813 [TBL] [Abstract][Full Text] [Related]
11. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine]. Kan GA; Borsuk EA; Vorob'eva MS Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927 [TBL] [Abstract][Full Text] [Related]
12. [Current status of the problem of tick-borne encephalitis]. Chunikhin SP; Levkovich EN Vestn Akad Med Nauk SSSR; 1980; (10):45-50. PubMed ID: 7001797 [No Abstract] [Full Text] [Related]
13. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394 [TBL] [Abstract][Full Text] [Related]
14. [Persistence of the tick-borne encephalitis virus and its consequences]. Pogodina VV Vestn Akad Med Nauk SSSR; 1983; (5):67-73. PubMed ID: 6868808 [No Abstract] [Full Text] [Related]
15. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus]. Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186 [TBL] [Abstract][Full Text] [Related]
16. [Immune response in vaccinated and non-vaccinated mice infected with tick-borne encephalitis virus]. Ignat'ev GM; Bukin EK; Otrashevskaia EV; Rasshchepkina MN; Vorob'eva MS Vopr Virusol; 2006; 51(5):22-7. PubMed ID: 17087061 [TBL] [Abstract][Full Text] [Related]
17. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis]. Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071 [TBL] [Abstract][Full Text] [Related]
19. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis]. Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697 [TBL] [Abstract][Full Text] [Related]
20. [A virulence study of tick-borne encephalitis virus strains isolated in the southern Soviet Far East]. Leonova GN; Muratkina SM; Krugliak SP Vopr Virusol; 1990; 35(5):399-401. PubMed ID: 2267782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]